ZEISS showcases comprehensive workflow for full spectrum of retina care at EURETINA

• IMPROVE PATHOLOGY DETECTION: Now CE mark approved, CIRRUS® PathFinderTM AI decision support tool streamlines OCT data review; ICGA for CLARUS® 700 offers FA + ICG simultaneous capture.
• ACCELERATE RETINA RESEARCH: AI-ready ZEISS Research Data Platform (RDP) empowers retina specialists to transform their clinical hypotheses into measurable outcomes through smarter, more efficient research.
• TRANSFORM VITREORETINAL TREAMENT: TDC VELOCETM, the new high-speed cutter for the DORC EVA NEXUSTM platform, unlocks new possibilities for the platform's proprietary VacuFlow VTi fluidics, further enabling the capabilities of the SMART IOPTM system of the EVA NEXUS to provide constant intraoperative stability during surgery on one of the market's most advanced dual-function, vitreoretinal and cataract surgical systems.
• SETTING THE PACE IN VISUALIZATION: ZEISS ARTEVO 850 and ZEISS ARTEVO 750, now with updated ZEISS CALLISTO eye software, support confident decision making and elevate the surgical workflow in vitreoretinal and combined phacovitrectomy procedures.

JENA, Germany, Aug. 26, 2025 /PRNewswire/ -- ZEISS Medical Technology will showcase its most advanced and comprehensive retina portfolio yet -- spanning from pathology detection and assessment to planning and treatment -- at the European Society of Retina Specialists (EURETINA) conference in Paris, France, from Sept. 4 – 7, 2025. ZEISS is one of very few companies offering the full spectrum of retinal care, combining diagnostic imaging, digital workflow tools and vitreoretinal surgical technologies, to support data continuity, procedural efficiency, and clinical decision-making across the retina care pathway.